2 ASX 200 shares rising on big news

What's getting investors excited today? Let's find out.

| More on:
Successful group of people applauding in a business meeting and looking very happy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market is rebounding nicely on Thursday following a solid session on Wall Street overnight.

Two ASX 200 shares that are contributing are listed below. Here's why they are pushing higher today:

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren share price is up 2.5% to $13.02. Investors have been buying this pharmaceutical company's shares after it revealed that its partner, Acadia Pharmaceuticals (NASDAQ: ACAD), has received Health Canada approval for Daybue (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients two years of age and older under the Priority Review process.

The ASX 200 share notes that this makes Daybue the first and only drug approved in Canada for the treatment of Rett syndrome.

Canada is included as part of the North America region under Neuren's agreement with Acadia. This means that potential sales in the country will be added to its US sales when calculating Neuren's royalties and sales milestone payments.

Neuren's CEO, Jon Pilcher, commented:

We are excited to see this first approval outside the United States, which is a significant milestone in the ongoing program to expand access to DAYBUE.

Neuren shares are now up 18% since this time last year.

Nextdc Ltd (ASX: NXT)

The NextDC share price is up 0.7% to $17.51. This follows news that the data centre operator has signed an agreement to purchase a new data centre site, Sydney S7.

The S7 site is located in Eastern Creek, approximately 45 kilometres west of Sydney's Central Business District and approximately 8 kilometres from its existing S4 site in Horsley Park, which is currently in planning. Management believes both sites represent a significant expansion opportunity in the Western Sydney Availability Zone.

In respect to S7, it notes that the 258,000sqm of developable land is in close proximity to a major electricity substation, as well as telecommunications, utilities, and associated public infrastructure.

S7 is expected to accommodate a data centre facility capable of approximately 550MW of capacity. This is huge, to say the least. As a comparison, NextDC's total contracted utilisation in FY 2024 was 172.6MW.

Though, this has come at a significant cost. NextDC notes that the purchase price of the S7 site is approximately $353 million. Subject to satisfaction of the conditions in the agreement, the ASX 200 share will progressively settle on the S7 land parcels across FY 2025. However, it will not attribute the S7 property holding costs within its FY 2025 underlying EBITDA guidance due to the uncertainty over the timing and quantum of such costs.

As a result, the company's FY 2025 capital expenditure guidance remains unchanged in the range of $1,300 million to $1,500 million.

NextDC's shares are up 43% over the past 12 months.

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a cracking end to the trading week for ASX investors.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why ARB, Cleanaway, Hub24, and RPMGlobal shares are storming higher today

These shares are ending the week with a bang. But why?

Read more »

Five people in an office high five each other.
Technology Shares

5 best performing ASX 200 tech shares of FY25

Some of the technology sector's biggest names led the charge in share price growth last financial year.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX shares that rose 100%+ in FY25

Let's see why these shares delivered huge returns for their shareholders in the last financial year.

Read more »

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a wild ride this Thursday.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Domino's, NRW, Pro Medicus, and WIA Gold shares are charging higher today

These shares are avoiding the market weakness and are pushing higher today. But why?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

UP 127% in a year, why is the Pro Medicus share price rocketing higher again today?

ASX investors are sending Pro Medicus shares flying higher on Thursday. But why?

Read more »

Happy man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX roared higher this hump day.

Read more »